These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Pharmacy formularies in integrated health systems. Osborne JA J Healthc Resour Manag; 1997; 15(1):18-20. PubMed ID: 10164678 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of pharmacy and therapeutics committee drug evaluation reports. Majercik PL; May JR; Longe RL; Johnson MH Am J Hosp Pharm; 1985 May; 42(5):1073-6. PubMed ID: 4003418 [TBL] [Abstract][Full Text] [Related]
28. Computer-based support system for formulary decisions. Senthilkumaran K; Shatz SM; Kalies RF Am J Hosp Pharm; 1987 Jun; 44(6):1362-6. PubMed ID: 3618613 [TBL] [Abstract][Full Text] [Related]
29. Developing guidelines for biotechnology drug use: experience with antithrombin III. Romac DR; Poole P; Owings JT; Mahackian K; Foulke G; Tharratt RS; Albertson TE Formulary; 1995 Sep; 30(9):520-3, 525-7, 531. PubMed ID: 10151737 [TBL] [Abstract][Full Text] [Related]
30. Purchasing and inventory control--past, present, and future. Skolaut MW; McAllister JC Am J Hosp Pharm; 1984 Mar; 41(3):522-5. PubMed ID: 6702857 [TBL] [Abstract][Full Text] [Related]
31. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities. Mittmann N; Knowles S Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000 [TBL] [Abstract][Full Text] [Related]
32. Formularies: the role of pharmacy-and-therapeutics (P&T) committees. Summers KH; Szeinbach SL Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049 [TBL] [Abstract][Full Text] [Related]
33. Twenty years' experience with drug information centers. Amerson AB; Wallingford DM Am J Hosp Pharm; 1983 Jul; 40(7):1172-8. PubMed ID: 6881155 [TBL] [Abstract][Full Text] [Related]
34. American Society of Hospital Pharmacists. Product selection survey. Am J Hosp Pharm; 1972 Jun; 29(6):506. PubMed ID: 5035970 [No Abstract] [Full Text] [Related]
35. Formulary management to reduce cost: P & T committee strategies. Roberts MJ; Summerfield MR Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289 [TBL] [Abstract][Full Text] [Related]
36. Formulary-control procedures in a staff-model health maintenance organization. Lyon RA Am J Hosp Pharm; 1990 Feb; 47(2):340-2. PubMed ID: 2106782 [TBL] [Abstract][Full Text] [Related]
37. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals. Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208 [TBL] [Abstract][Full Text] [Related]
38. Analysis of drug reports for the P&T Committee. Longe RL; Cross GW; Riley MW Hosp Formul; 1978 Mar; 13(3):228-9. PubMed ID: 10306915 [No Abstract] [Full Text] [Related]
39. ASHP statement on hospital drug control systems. Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439 [No Abstract] [Full Text] [Related]
40. Antimicrobial formulary management: meeting the challenge in a health maintenance organization. Carlson JA Pharmacotherapy; 1991; 11(1 ( Pt 2)):32S-35S. PubMed ID: 2011571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]